Incidence and risk factors of pain crisis after hematopoietic cell transplantation for sickle cell disease
Recurrence of VOC requiring hospitalization or treatment occurs in 8.7% of patients after HCT with stable donor engraftment in SCD.GF, age at HCT, prior hi